Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China
Min Liu,* Honghong Yang,* Qian Liu,* Kun He, Jing Yuan, Yaokai Chen Department of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yaokai Chen, Emai...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-12-01
|
| Series: | Infection and Drug Resistance |
| Subjects: | |
| Online Access: | https://www.dovepress.com/amphotericin-b-colloidal-dispersion-is-efficacious-and-safe-for-the-ma-peer-reviewed-fulltext-article-IDR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850256178150375424 |
|---|---|
| author | Liu M Yang H Liu Q He K Yuan J Chen Y |
| author_facet | Liu M Yang H Liu Q He K Yuan J Chen Y |
| author_sort | Liu M |
| collection | DOAJ |
| description | Min Liu,* Honghong Yang,* Qian Liu,* Kun He, Jing Yuan, Yaokai Chen Department of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yaokai Chen, Email yaokaichen@hotmail.comBackground: Amphotericin B deoxycholate (AmB-D) have potential toxic effects in the treatment of talaromycosis, and high-quality, non-generic liposomal AmB (L-AMB) is still inaccessible in many regions of China. As such, the efficacy and safety of alternative drugs warrant further investigation for the management of talaromycosis. This study aimed to compare the efficacy and safety of Amphotericin B Colloidal Dispersion (ABCD) and AmB-D for the treatment of talaromycosis in a retrospective cohort of HIV-infected patients.Methods: This was a retrospective study and the data of HIV-infected patients with talaromycosis who received ABCD or AmB-D from January 2018 to December 2022, were retrospectively collected and analyzed. We compared the efficacy and safety of the two antifungal drugs.Results: Overall, 38 patients receiving ABCD and 33 patients receiving AmB-D were included. The conversion rates to fungal negativity at one week post-treatment were 86.84% (33/38) in the ABCD group and 90.09% (30/33) in the AmB-D group, which reached 100.00% in both groups at two weeks post-treatment. A higher symptom remission rate was observed at two weeks in the ABCD group compared with the AmB-D group (94.74% vs 75.76%; p=0.003). Additionally, the serum creatinine level significantly increased from baseline in the AmB-D group, whereas it did not increase significantly in the ABCD group. Furthermore, significantly fewer patients discontinued antifungal treatment due to drug intolerance in the ABCD group, and the incidences of leukopenia and elevated creatinine levels were lower in the ABCD group compared with the AmB-D group.Conclusion: ABCD has a clinical efficacy comparable to AmB-D, with higher symptom remission rate, lower nephrotoxicity, and lower bone marrow suppression, indicating that ABCD may be an appropriate alternative option for the clinical management of talaromycosis.Keywords: talaromycosis, human immunodeficiency virus, amphotericin B deoxycholate, amphotericin B colloidal dispersion, efficacy, safety |
| format | Article |
| id | doaj-art-2c36938ea8644cb7b176710dda424bf7 |
| institution | OA Journals |
| issn | 1178-6973 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Infection and Drug Resistance |
| spelling | doaj-art-2c36938ea8644cb7b176710dda424bf72025-08-20T01:56:42ZengDove Medical PressInfection and Drug Resistance1178-69732024-12-01Volume 175581559398371Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in ChinaLiu MYang HLiu QHe KYuan JChen YMin Liu,* Honghong Yang,* Qian Liu,* Kun He, Jing Yuan, Yaokai Chen Department of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yaokai Chen, Email yaokaichen@hotmail.comBackground: Amphotericin B deoxycholate (AmB-D) have potential toxic effects in the treatment of talaromycosis, and high-quality, non-generic liposomal AmB (L-AMB) is still inaccessible in many regions of China. As such, the efficacy and safety of alternative drugs warrant further investigation for the management of talaromycosis. This study aimed to compare the efficacy and safety of Amphotericin B Colloidal Dispersion (ABCD) and AmB-D for the treatment of talaromycosis in a retrospective cohort of HIV-infected patients.Methods: This was a retrospective study and the data of HIV-infected patients with talaromycosis who received ABCD or AmB-D from January 2018 to December 2022, were retrospectively collected and analyzed. We compared the efficacy and safety of the two antifungal drugs.Results: Overall, 38 patients receiving ABCD and 33 patients receiving AmB-D were included. The conversion rates to fungal negativity at one week post-treatment were 86.84% (33/38) in the ABCD group and 90.09% (30/33) in the AmB-D group, which reached 100.00% in both groups at two weeks post-treatment. A higher symptom remission rate was observed at two weeks in the ABCD group compared with the AmB-D group (94.74% vs 75.76%; p=0.003). Additionally, the serum creatinine level significantly increased from baseline in the AmB-D group, whereas it did not increase significantly in the ABCD group. Furthermore, significantly fewer patients discontinued antifungal treatment due to drug intolerance in the ABCD group, and the incidences of leukopenia and elevated creatinine levels were lower in the ABCD group compared with the AmB-D group.Conclusion: ABCD has a clinical efficacy comparable to AmB-D, with higher symptom remission rate, lower nephrotoxicity, and lower bone marrow suppression, indicating that ABCD may be an appropriate alternative option for the clinical management of talaromycosis.Keywords: talaromycosis, human immunodeficiency virus, amphotericin B deoxycholate, amphotericin B colloidal dispersion, efficacy, safetyhttps://www.dovepress.com/amphotericin-b-colloidal-dispersion-is-efficacious-and-safe-for-the-ma-peer-reviewed-fulltext-article-IDRtalaromycosishuman immunodeficiency virusamphotericin b deoxycholateamphotericin b colloidal dispersionefficacysafety |
| spellingShingle | Liu M Yang H Liu Q He K Yuan J Chen Y Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China Infection and Drug Resistance talaromycosis human immunodeficiency virus amphotericin b deoxycholate amphotericin b colloidal dispersion efficacy safety |
| title | Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China |
| title_full | Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China |
| title_fullStr | Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China |
| title_full_unstemmed | Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China |
| title_short | Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China |
| title_sort | amphotericin b colloidal dispersion is efficacious and safe for the management of talaromycosis in hiv infected patients results of a retrospective cohort study in china |
| topic | talaromycosis human immunodeficiency virus amphotericin b deoxycholate amphotericin b colloidal dispersion efficacy safety |
| url | https://www.dovepress.com/amphotericin-b-colloidal-dispersion-is-efficacious-and-safe-for-the-ma-peer-reviewed-fulltext-article-IDR |
| work_keys_str_mv | AT lium amphotericinbcolloidaldispersionisefficaciousandsafeforthemanagementoftalaromycosisinhivinfectedpatientsresultsofaretrospectivecohortstudyinchina AT yangh amphotericinbcolloidaldispersionisefficaciousandsafeforthemanagementoftalaromycosisinhivinfectedpatientsresultsofaretrospectivecohortstudyinchina AT liuq amphotericinbcolloidaldispersionisefficaciousandsafeforthemanagementoftalaromycosisinhivinfectedpatientsresultsofaretrospectivecohortstudyinchina AT hek amphotericinbcolloidaldispersionisefficaciousandsafeforthemanagementoftalaromycosisinhivinfectedpatientsresultsofaretrospectivecohortstudyinchina AT yuanj amphotericinbcolloidaldispersionisefficaciousandsafeforthemanagementoftalaromycosisinhivinfectedpatientsresultsofaretrospectivecohortstudyinchina AT cheny amphotericinbcolloidaldispersionisefficaciousandsafeforthemanagementoftalaromycosisinhivinfectedpatientsresultsofaretrospectivecohortstudyinchina |